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Abstract 
Background: Gestational diabetes (GDM) is a complication of 
pregnancy that is characterized by intolerance to carbohydrates and 
metabolic diseases. Gestational diabetes has many maternal and fetal 
complications that need to be carefully controlled. Therefore, the aim 
of the present study was to investigate the effect of calcium-D 
supplementation on glucose control of patients with gestational 
diabetes. 
Methods: This randomized clinical trial study was performed on 84 
pregnant women with GDM. Some inclusion criteria included a 
positive one-step test during the 24th-28th week of pregnancy and 
definitive diagnosis of GDM and some exclusion criteria including 
patients with a previous history of diabetes who required insulin 
therapy during the intervention. The intervention group were given 
routine treatment and calcium supplements plus vitamin D and the 
control group were given routine treatment only. Fasting blood glucose 
was measured monthly in both groups until the end of pregnancy. All 
analyses were performed using SPSS software version 16 and related 
tests like mean±SD, chi-square test and multivariate logistic 
regression. Significant level was set at 0.05. 
Results: Of the 84 patients examined, the mean age was 29.4 ± 5.2 
years old and there were no significant differences between the two 
groups (Pvalue=0.189). The mean BMI of all patients was 25.31 ± 2.72 
kg/m2 and there was no significant difference between the two groups 
(Pvalue=0.312). The mean of the FBS level at the end of the study in 
the case group was 91.5 ± 12.9 mg/dl and in the control group it was 
98.9 ± 15.8 mg/dl, which was significantly lower in the case group 
(P=0.014). GDM variables were significantly associated with a 
positive history of diabetes mellitus (Pvalue<0.033), previous history 
of GDM (Pvalue<0.013) and FBS (Pvalue<0.001) and there was no 
significant relationship with other variables. 
Conclusions: The results of this study showed that calcium-D 
supplementation has a significant effect on glucose control in patients 
with GDM and its use is recommended in these patients. 
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Introduction 
Gestational diabetes mellitus (GDM) is a complication of 
pregnancy which is defined as intolerance of carbohydrates and 
metabolic disorders.1 Approximately 7% of all pregnant 
women in America are GDM, but its prevalence is between 1% 
and 4% of all pregnancies in the world which depends on the 
population studied and the criteria for diagnosis.2 Generally, 
4.7% of pregnant women in Iran have this condition.3 Various 
factors for this condition include higher age at the time of the 
first pregnancy, stressful living conditions and sedentary 
lifestyles with little or no physical activity, inappropriate diet 
and high intake of food have been reported which leads to 
increased risk.4 GDM is related to insulin resistance and 
vascular inefficiency, vascular disease, macrosomia, neonatal 
hypoglycemia, increased bilirubinemia, cesarean section, 
pregnancy blood pressure, and early delivery.5-6 Current GDM 
treatments include a diet with a low glycemic index, for 
carbohydrate restriction, the use of some glycemic control 
agents and insulin therapy.7 A number of recent studies have 
shown that supplements of calcium and vitamin D for patients 
with GDM may affect pregnancy outcomes.8 It has been 
observed in several studies that 25 hydroxy vitamin D levels 
are significantly lower in diabetic patients than in healthy 
subjects. Although the complementary effect of calcium plus 
vitamin D supplementation on glucose homeostasis and 
oxidative stress biomarkers have not been tested in GDM 
patients, some studies have reported their separate 
supplemental effects on metabolic profile and oxidative stress 
in these patients.9-10 Our previous study on GDM patients 
showed that 6 weeks of vitamin D supplementation resulted in 
improved insulin function and decreased total cholesterol and 
LDL.11-12 It is assumed that calcium and vitamin D do not 
function independently and work together. Previous reports 
have shown that their complementary supplementation is much 
more effective than a separate supplement of calcium or 
vitamin D on the metabolic profile.13-14 The most important 
known role of vitamin D is that it helps calcium balance and 
absorption, but recently, studies have shown that it plays a role 
in the development of the brain and the immune system of the 
fetus and in the prevention of many autoimmune diseases, such 
as type I diabetes and multiple sclerosis.15 Furthermore, given 
the need for vitamin D and calcium during pregnancy, the lack 
of proper nutrition during this important period of life may 
increase the risk of GDM.16 Several mechanisms have been 
proposed for linking vitamin D and type II diabetes. These 
mechanisms relate to diabetes and vitamin D in three ways and 
affect insulin secretion, the resistance of environmental tissues 
to insulin and inflammation.17-18 The benefits of supplementing 
with calcium and vitamin D may be due to their effect on cell 
cycle regulation, the activation of antioxidant enzymes and 
parathyroid hormone (PTH) suppression, and their role in 
metabolic profiles and oxidative stress.18 The effect of 
simultaneous supplementation of calcium plus vitamin D on 
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insulin function, lipid profile, inflammatory factors, and 
oxidative stress biomarkers in GDM are not yet clear. 
Therefore, the present study was designed to investigate the 
effect of Calcium-D supplementation on control of glycemic 
control in patients with gestational diabetes who referred to 
Shahroud Bahar Hospital during 2018. 
Materials and Methods  
This study was a parallel randomized clinical trial study 
that was performed on 84 pregnant women with gestational 
diabetes who were referred to Bahar hospital in Shahroud 
(Northeastern Iran) between January and December 2018 
(figure 1). Patients were randomly divided into two groups of 
42 cases (taking calcium supplements plus vitamin D) and 42 
in the control group (routine only). Since the prevalence of 
vitamin D deficiency is about 50% in Iranian pregnant women, 
the selection of patients was done in the two groups of 
intervention and control randomly without measuring vitamin 
D levels.  
Inclusion criteria: pregnant women aged 18 and 40 years 
old, positive one-step test (75 grams of pure glucose and 2 
hours later glucose measurement) during the 24th-28th week of 
pregnancy and definitive diagnosis of GDM. 
Pregnant women with no previous diagnosis of glucose 
intolerance were screened and GDM was diagnosed using 
ADA criteria. Thus, the women whose plasma glucose had one 
of the fasting blood glucose levels≥95 mg/dl, one hour≥180 
mg/dl and two hours≥155 mg/dl, as people with GDM were 
considered suitable for the study.19 
Exclusion criteria: patients with a previous history of 
diabetes, premature rupture of the membrane, sudden 
discontinuation of placenta, gestational hypertension, 
pregnancy congestion, chronic hypertension, hypothyroidism, 
or of those requiring insulin therapy during the intervention 
(Plasma Glucose Fasting 5.8 mmol/L, and 2 hours post-fasting 
blood glucose greater than 6.7 mmol/L) and also, those who did 
not give written consent to enter the study or requested to leave 
the study at some point. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Consort diagram of study 
Selection of 84 eligible patients 
Obtain informed consent 
 
 
 
 
 
 
 
Control group:  
Routine treatment 
 
 
 
 
 
 
 
 
 
Intervention group: 
Routine treatment + Calcium supplements plus vitamin D 
 
 
 
 
 
 
 
Measurement of FBS on the monthly to end pregnancy  
 
 
 
 
 
 
 
Measurement of FBS on the monthly to end pregnancy  
End the study and review the results 
Ghanbari et al 
28       |         International Journal of Health Studies 2020;6(1)  
For patients in the intervention group, 500 mg of calcium 
carbonate per day plus 1000 units of vitamin D was 
administered once daily in subjects with routine gestational 
diabetes mellitus during the study and in the control group, no 
case group drugs were administered and only routine 
gestational diabetes mellitus therapy was prescribed. 
*************EDITOR’S NOTE; PLEASE CHECK 
PREVIOUS SENTENCE******************** The 
duration of the intervention continued until the end of 
pregnancy. It should be noted that routine gestational diabetes 
therapy continued for both groups during this period. 
Participants were also asked not to change their physical 
activity or dietary intake during the study, and not add any 
other supplements apart from the supplement provided by the 
researchers. Fasting blood glucose was measured monthly in 
both groups until the end of pregnancy. 
Descriptive statistics including mean and standard 
deviation, as well as relative frequency were used to describe 
the data. To examine the relationships and comparisons 
between the two groups the chi-square test and multivariate 
logistic regression were used to evaluate the odds of each of the 
variables. All analyses were performed using SPSS software 
version 16 and a significant level (Pvalue<0.05). Sample size 
using Epi info 7.2 at a significant level of 5% and a power of 
80% was determined, and was equal to 42 people in each group 
and a total of 84 people. 
This study with the code of ethics number 
(IR.SHMU.REC.1396.41) from the research deputy of 
Shahroud university of medical sciences and with code 
IRCT20100102002954N11 has been registered in the Iranian 
clinical trials system. The essential information and the 
objectives of the study were explained to the patients, and 
written consent was obtained for participation in the research. 
Results 
In this study, the mean age of all patients was 29.4 ± 5.2 
years and there was no significant difference between the two 
groups (Pvalue=0.189). The mean BMI of all patients was 
25.31 ± 2.72 kg/m2 and there was no significant difference 
between the two groups (Pvalue=0.312). The mean of the FBS 
level at the end of the study in the case group was 91.5 ± 12.9 
mg/dl and in the control group was 98.9 ± 15.8 mg/dl, showing 
it was significantly lower in the case group (Pvalue=0.014). 
The results of the biochemical tests of patients in the two 
groups are shown in table 1. In this study, independent 
variables with GDM were investigated in a multivariate 
regression model. As shown in table 2, GDM variables were 
significantly associated with a positive history of diabetes 
mellitus (Pvalue<0.033), the previous history of GDM 
(Pvalue<0.013) and FBS (Pvalue<0.001) and there was no 
significant relationship with other variables. The results of the 
multivariate logistic regression model are presented in table 2. 
This study with the code of ethics number (IR.SHMU.REC. 
1396.41) was obtained from the research deputy of Shahroud 
university of medical sciences. Informed consent was obtained 
from all individual participants included in the study 
 
Table 1. Results of biochemical tests in two groups 
Lab test 
Case group 
Mean±SD 
Control group 
Mean±SD 
Total 
Mean±SD 
Pvalue 
FBS at the beginning of the study (mg/dl) 103.7 ± 12.5 101.5 ± 15.5 102.2 ± 14.5 0.142 
FBS at the end of the study (mg/dl) 91.5 ± 12.9 98.9 ± 15.8 95.7 ± 13.5 0.014 
BS of 2hpp at the beginning of the study (mg/dl) 156.7 ± 18.6 154.2 ± 16.3 135.5 ± 16.8 0.103 
BS of 2hpp at the end of the study (mg/dl) 132.3 ± 11.7 140.4 ± 15.6 115.5 ± 13.8 0.011 
HbA1c at the beginning of the study (%) 5.2 ± 1.3 5.1 ± 1.1 5.1 ± 1.7 0.127 
HbA1c at the end of the study (%) 4.8 ± 2.1 5.0 ± 1.8 4.9 ± 1.8 0.079 
 
Table 2. Relationship between independent variables with fatty liver in multivariate logistic regression model 
Independent variables Odds ratio 95% Confidence Pvalue 
Age category 
18 to 35 years 
Less than 18 years 
More than 35 years 
1 .000 
0.812 
1.091 
 
1.082-0.0672 
1.251-0.0912 
 
0.088 
0.063 
Gravity 
1 Pregnancy 
2-3 Pregnancy 
More than 3 Pregnancy 
1.000 
1.109 
1.188 
 
1.313-0.915 
1.388-0.952 
 
0.069 
Body mass index (kg/m2) 
18-25 
<18 
>25 
1.000 
0.823 
1.275 
 
0.985-0.756 
1.435-0.962 
 
0.075 
0.053 
Positive history of diabetes mellitus 
Negative 
Positive 
1.000 
1.405 
 
1.748-1.011 
 
0.033 
Previous history of GDM 
Negative 
Positive 
1.000 
1.511 
 
1.823-1.271 
 
0.013 
Previous history of stillborn 
Negative 
Positive 
1.000 
1.026 
 
1.142-0.909 
 
0.079 
Fasting blood sugar (mg/dl) 
<92 
92-125 
>126 
1.000 
1.451 
2.885 
 
1.754-1.256 
3.213-2.615 
 
0.012 
0.001 
BS of 2hpp (mg/dl) 
<135 
135-153 
>153 
1.000 
1.121 
1.172 
 
1.354-0.856 
1.413-0.815 
 
0.059 
0.053 
HbA1c (%) 
<5.6 
5.6-6.5 
>6.5 
1.000 
1.028 
1.049 
 
1.182-0.957 
1.213-0.915 
 
0.079 
0.065 
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Discussion 
The results of this study showed that vitamin D is effective 
in reducing glycemic gestational diabetes, in such a way that 
the fasting and glucose levels of 2 hours in the intervention 
group were less than the control group. Holick et al., in their 
study on a new approach to the pathogenesis of GDM and 
insulin resistance, concluded that there is a correlation between 
vitamin D deficiency and gestational diabetes mellitus. 
Therefore, it has been suggested that administering vitamin D 
supplementation in pregnancy is necessary to control many 
conditions, especially GDM. This finding is in agreement with 
the results of the present study.19 The most important known 
role of vitamin D is in helping calcium balance and absorption, 
but recently, studies have shown vitamin D plays a role in the 
development of the brain and the immune system of the fetus 
and prevention of many autoimmune diseases, such as diabetes 
and multiple sclerosis in later years.  
Lau et al., in a clinical study of hyperglycemia and its 
complications in pregnancy have shown that vitamin D levels 
which indirectly correlate with poor blood glucose control, and 
with correct vitamin D levels, can reduce the incidence of 
gestational diabetes and its complications.20 This finding is 
largely aligned with the results of our study. 
Maghbooli et al., in their study, investigated the effect of 
supplementation of calcium and vitamin D on insulin function, 
lipid parameters, inflammatory factors and oxidative stress 
biomarkers in 56 pregnant women with GDM and found that 
following a prescription of calcium supplements with vitamin 
D, significantly decreased levels of fasting blood glucose 
compared with those of the control group; it is consistent with 
the findings of our research.21 
Baker et al., found that calcium supplementation with 
vitamin D in women with GDM has beneficial effects on 
metabolic parameters and can reduce fasting glucose levels, but 
it does not have a significant effect on random sugars.22 This 
finding is partly consistent with the results of our study but 
contrasts with non-fasting sugar and perhaps the reason for this 
is the timing of the non-fasting study of the present study or the 
type of diet.  
Poel et al., reviewed the effect of supplementation and 
vitamin D in controlling abnormalities of beta cells in pregnant 
women and showed that prescribing this supplement with 
vitamin D can greatly increase the levels of natural blood sugar 
in these women.23 This finding is similar to that of our 
research. 
In a study by Akhlaghi et al., it was found that many 
maternal and fetal complications are a risk during gestational 
diabetes and it is necessary to control diabetes as soon as 
possible and one of the most important ways is to correct the 
nutritional status and use of appropriate supplements, including 
calcium- D.24 The discovery of the importance of using 
calcium plus vitamin D in the Pal study is similar to the 
findings of this study. 
As has been seen, the present study showed a strong 
relationship between the history of diabetes mellitus, previous 
history of GDM and fasting blood sugar with the incidence of 
GDM. Considering the pathogenesis of diabetes and 
progressive degeneration of pancreatic beta cells in diabetic 
patients and insulin deficiency or in decreasing the sensitivity 
of cells to insulin, these factors seem to significantly predispose 
pregnant women to gestational diabetes, therefore it is 
necessary to carefully observe the history of maternal diabetes 
in pregnancy and even before pregnancy.25-27 
The results of this study showed that calcium -D 
supplementation can significantly reduce the level of glucose 
and control the condition of women with GDM, so it is 
recommended that Calcium-D supplementation be prescribed 
for this group of women. 
The limitations of this research include the lack of precise 
control over the diet of pregnant women during pregnancy and 
inevitably, one has to rely on what the subjects say about their 
amount of carbohydrate intake. Therefore, it is of upmost 
importance that the subjects be educated and persuaded to pay 
attention to the maximum dietary intake allowed. 
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